The closing of this JV is a long-anticipated event with no new financial surprises — the price and structure were disclosed over a year ago. Monitor Arbex's operational performance in upcoming quarters for evidence of value creation, and watch for any credit rating implications from the incremental ~USD 1.0 billion in JV debt.
Price Chart
Executive Summary
Suzano completed its previously announced acquisition of a 51% equity interest in FamPro Tissue Holdings B.V. (Arbex) from Kimberly-Clark for a total payment of USD 1.3 billion (R$6.7 billion), with the joint venture assuming approximately USD 1.0 billion in net debt. The transaction closes a year-long process and establishes Suzano as the controlling shareholder in a tissue paper joint venture with Kimberly-Clark, with a defined governance structure including former Suzano CEO Walter Schalka as Chairman.
Key Facts
- Suzano completed the acquisition of a 51% equity interest in FamPro Tissue Holdings B.V. (Arbex) from Kimberly-Clark for USD 1.3 billion (R$6.7 billion)
- The joint venture has total net debt of approximately USD 1.0 billion from financing raised in connection with the transaction
- Suzano is the controlling shareholder of the joint venture
- Former Suzano CEO Walter Schalka appointed Chairman of Arbex's Board of Directors
- Transaction was previously announced on June 5, 2025 and May 28, 2026, and all conditions precedent have now been satisfied
Financial Impact
Suzano paid USD 1.3 billion (R$6.7 billion) for a 51% stake, with the JV assuming ~USD 1.0 billion in net debt. Total enterprise value of the acquired stake is approximately USD 1.8 billion including proportional debt.
Risk Factors
- Integration risk: combining tissue operations from two different corporate cultures and systems
- Leverage risk: the JV carries ~USD 1.0 billion in net debt, adding to Suzano's consolidated leverage
- Execution risk: Suzano is controlling a new business line (tissue) where it has less operational history than its core pulp business
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001628280-26-046329 |
| Document: a20260701-suzano_6k.htm | 0001628280-26-046329 |
| Document: 0001628280-26-046329-index-headers.html | 0001628280-26-046329 |
| Document: 0001628280-26-046329-index.html | 0001628280-26-046329 |
| Document: 0001628280-26-046329.txt | 0001628280-26-046329 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 21, 2026 5d ago | 6-K | $8.53 | awaiting T+20 | — | $8.64 (+1.29%) |
Oct 15, 2026 11d ago | 6-K | $8.50 | awaiting T+20 | — | $8.64 (+1.65%) |
Aug 31, 2026 8w ago | 6-K | $8.86 $8.57 | ▼ −3.27% | ▼ −3.59% | $8.64 (−2.48%) |
Aug 20, 2026 9w ago | 6-K | $8.78 $9.25 | ▲ +5.35% | ▲ +5.88% | $8.64 (−1.59%) |
Aug 13, 2026 10w ago | 6-K | $7.99 $9.36 | ▼ −17.15% | ▼ −18.89% | $8.64 (−8.14%) |
Aug 4, 2026 11w ago | 6-K | $8.35 $8.86 | ▲ +6.11% | ▲ +7.35% | $8.64 (+3.47%) |
Jul 1, 2026 16w ago | 6-K | $7.81 $8.30 | ▲ +6.27% | ▲ +8.46% | $8.64 (+10.63%) |
May 28, 2026 21w ago | 6-K | $8.26 $7.72 | ▼ −6.54% | ▼ −3.39% | $8.64 (+4.60%) |
May 11, 2026 24w ago | 6-K | $8.75 $8.02 | ▼ −8.34% | ▼ −6.62% | $8.64 (−1.26%) |
May 7, 2026 24w ago | 6-K | $8.87 $8.18 | ▼ −7.78% | ▼ −7.80% | $8.64 (−2.59%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers